title: Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48).
authors.affiliation: TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. cruff@partners.org
authors.forename: Christian T
authors.initials: CT
authors.lastname: Ruff
authors.forename: Robert P
authors.initials: RP
authors.lastname: Giugliano
authors.forename: Elliott M
authors.initials: EM
authors.lastname: Antman
authors.forename: Sharon E
authors.initials: SE
authors.lastname: Crugnale
authors.forename: Tomas
authors.initials: T
authors.lastname: Bocanegra
authors.forename: Michele
authors.initials: M
authors.lastname: Mercuri
authors.forename: James
authors.initials: J
authors.lastname: Hanyok
authors.forename: Indravadan
authors.initials: I
authors.lastname: Patel
authors.forename: Minggao
authors.initials: M
authors.lastname: Shi
authors.forename: Dan
authors.initials: D
authors.lastname: Salazar
authors.forename: Carolyn H
authors.initials: CH
authors.lastname: McCabe
authors.forename: Eugene
authors.initials: E
authors.lastname: Braunwald